TRADING UPDATES: Ondine study results put back; Helix seals purchase
13th Jul 2026 20:05
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 13.75p on 15-07-2026 at 10:35:20 |
|---|---|
| Change | 0.00p 0% |
| Buy | 14.00p |
| Sell | 13.50p |
| Last Trade: | Sell 10,476.00 at 13.695p |
| Day's Volume: | 117,547 |
| Last Close: | 13.75p |
| Open: | 13.75p |
| ISIN: | CA68234M2058 |
| Day's Range | 13.75p - 13.75p |
| 52wk Range: | 8.00p - 18.25p |
| Market Capitalisation: | £71.44m |
| VWAP: | 13.7456p |
| Shares in Issue: | 519.55m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ondine Biomed (OBI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,476 | 13.695p | Ordinary |
11:35:18 - 15-Jul-26 |
| Sell* | 7,071 | 13.6876p | Ordinary |
08:12:37 - 15-Jul-26 |
| Unknown* | 100,000 | 13.755p | Ordinary |
08:00:37 - 15-Jul-26 |
| Unknown* | 100,000 | 14.00p | Negotiated Trade |
16:17:52 - 14-Jul-26 |
| Unknown* | 110,000 | 13.55p | Negotiated Trade |
14:26:54 - 14-Jul-26 |
| Buy* | 39,436 | 14.20p | Ordinary |
12:20:57 - 14-Jul-26 |
| Buy* | 35 | 14.00p | Ordinary |
09:31:03 - 14-Jul-26 |
| Unknown* | 48,192 | 14.00p | Ordinary |
09:16:50 - 14-Jul-26 |
| Buy* | 28,694 | 13.94p | Ordinary |
08:59:22 - 14-Jul-26 |
| Buy* | 25,000 | 13.83p | Ordinary |
08:35:15 - 14-Jul-26 |
Ondine Biomed (OBI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Jul 2026 7:00 am | RNS | Update on US Phase 3 Pivotal Study |
| 1st Jul 2026 7:00 am | RNS-R | Keynote Address at 8th Annual Photodynamic Day |
| 30th Jun 2026 6:15 pm | RNS | Result of AGM and voting results |
| 30th Jun 2026 7:00 am | RNS | Leeds drops SSI 78% over Mupirocin with Steriwave |
| 22nd Jun 2026 7:00 am | RNS | Update on US Phase 3 Pivotal Study |
| 18th Jun 2026 7:00 am | RNS | Leeds Drops SSIs by 78.5% in Complex Brain Surgery |
| 8th Jun 2026 4:25 pm | RNS | Grant of Options and RSUs, and Issue of Warrants |
| 4th Jun 2026 7:00 am | RNS | Notice of AGM |
| 4th Jun 2026 7:00 am | RNS | 2025 Full Year Results and Annual Report |
| 28th May 2026 7:00 am | RNS | Notice of Results and Investor Presentation |